© 1999 by European Society of Cardiology
REGULAR ARTICLE: THE GENETIC AND MOLECULAR BASES OF CLINICAL ARRHYTHMIC DISEASES
The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death—the Brugada syndrome
*Arrhythmia Unit, Cardiovascular Institute, Hospital Clínic, University of Barcelona Barcelona, Spain;
Cardiovascular Research and Teaching Institute Aalst, Cardiovascular Center Aalst, Belgium;
Department of Cardiology, Baylor College of Medicine Houston, Texas, U.S.A.
In 1992 a new syndrome was described consisting of syncopal episodes and/or sudden death in patients with a structurally normal heart and an electrocardiogram (ECG) characteristic of right bundle branch block with ST segment elevation in leads V1to V3. The disease is genetically determined, with an autosomal dominant pattern of transmission. Three different mutations that affect the structure and function of the cardiac sodium channel gene SCN5A have been identified. Two mutations result in total loss of function of the sodium channel. The other mutation results in acceleration of the recovery of the sodium channel from inactivation. The incidence of the disease is difficult to estimate, but it causes 4 to 10 sudden deaths per 10 000 inhabitants per year in areas like Thailand and Laos. In these countries, the disease represents the most frequent cause of death in young adults. Up to 50% of the yearly sudden deaths in patients with a structurally normal heart are caused by this syndrome. The diagnosis is easily made by means of the ECG. The presence of concealed and intermittent forms, however, make the diagnosis difficult in some patients. The ECG can be modulated by changes in autonomic balance and the administration of antiarrhythmic drugs. Beta-adrenergic stimulation normalizes the ECG, while intravenous ajmaline, flecainide or procainamide accentuate ST segment elevation and are capable of unmasking concealed and intermittent forms of the disease. Recent data suggest that loss of the action potential dome in the right ventricular epicardium but not the endocardium underlies ST segment elevation seen in the Brugada syndrome. Also, electrical heterogeneity within the right ventricular epicardium leads to the development of closely coupled extrasystoles via a phase 2 reentrant mechanism, which then precipitates ventricular tachycardia–ventricular fibrillation. Right ventricular epicardium is preferentially affected because of the predominance of transient outward current in this tissue. Antiarrhythmic drugs like amiodarone and beta-blockers do not prevent sudden death in symptomatic or asymptomatic individuals. Gene therapy may offer a cure in future years. Implantation of an automatic cardioverter–defibrillator is the only currently proven effective therapy.
Key Words: Sudden death, bundle branch block, Brugada syndrome, genetic diseases, cardiac arrhythmias
Correspondence: Dr Pedro Brugada, Cardiovascular Center, O.L.V. Hospital, Moorselbaan 190, 9300 Aalst, Belgium.
[1] Brugada P and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992; 20: 1391–1396.
[2] Bjerregaard P, Gussak I, Kotar SL. Recurrent syncope in a patient with prominent J-wave. Am Heart J 1994; 127: 1426–1430.
[3] Yan GX and Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 1996; 93: 372–379.
[4] Priori SG, Diehl L, Schwartz PJ, Podrid PJ, Kowey PR. Torsade de pointes. Cardiac Arrhythmia 1995; Baltimore Williams and Wilkins pp. 951–963.
[5] El-Sherif N. Polymorphic ventricular tachycardia. In Podrid PJ and Kowey PR (Eds.). Cardiac Arrhythmia 1995; Baltimore Williams and Wilkins pp. 936–5.
[6] Brugada P and Brugada J. A distinct clinical and electrocardiographic syndrome: right bundle branch block, persistent ST segment elevation with normal QT interval and sudden cardiac death. Pacing Clin Electrophysiol 1991; 14: 746.
[7] Osher HL and Wolff L. Electrocardiographic pattern simulating acute myocardial injury. Am J Med Sci 1953; 226: 541–545.
[8] Eideken J. Elevation of RS-T segment, apparent or real in right precordial leads as probable normal variant. Am Heart J 1954; 48: 331–339.
[9] Levine HD, Wanzer SH, Merrill JP. Dialyzable currents of injury in potassium intoxication resembling acute myocardial infarction or pericarditis. Circulation 1960; 6: 920–928.
[10] Roesler H. An electrocardiographic study of high take-off of the R(R)-T segment in right precordial leads. Altered repolarisation. Am J Cardiol 1960; 6: 920–928.
[11] Calo AA. The triad secondary R wave, RS-T segment elevation and T waves inversion in right precordial leads: a normal electrocardiographic variant. G Ital Cardiol 1975; 5: 955–960.
[12] Martini B, Nava A, Thiene G, et al. Ventricular fibrillation without apparent heart disease. Description of six cases. Am Heart J 1989; 118: 1203–1209.
[13] Nademanee K, Veerakul G, Nimmannit S, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997; 96: 2595–2600.
[14] Rampazzo A, Nava A, Erne P, et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23–Q24. Hum Mol Genet 1994; 3: 959–962.
[15] Rampazzo A, Nava A, Erne P, et al. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42–Q43. Hum Mol Genet 1995; 4: 2151–2154.
[16] Severini GM, Krajinovic M, Pinamonti B, et al. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 1996; 31: 193–200.
[17] Rampazzo A, Nava A, Miorin M, et al. ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. Genomics 1997; 15: 259–263.
[18] Coonar AS, Protonotarios N, Tsatsopoulou A, et al. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998; 97: 2049–2058.
[19] Suzuki J, Tsubone H, Sugano S. Characteristics of ventricular activation and recovery patterns in the rat. J Vet Med Sci 1992; 54: 711–716.
[20] Lukas A and Antzelevitch C. Differences in the electrophysiologic response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current. Circulation 1993; 88: 2903–2915.
[21] Antzelevitch C, Sicouri S, Lukas A, et al. Clinical implications of electrical heterogeneity in the heart: The electrophysiology and pharmacology of epicardial, M and endocardial cells. In Podrid PJ and Kowey PR (Eds.). Cardiac arrhythmia: Mechanism and management 1995; Baltimore William and Wilkins pp. 88–107.
[22] Litovsky SH and Antzelevitch C. Differences in the electrophysiologic response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. Circ Res 1990; 67: 615–627.
[23] Krishnan SC and Antzelevitch C. Flecainide-induced arrhythmia in canine ventricular epicardium: Phase 2 Reentry? Circulation 1993; 87: 562–572.
[24] Krishnan SC and Antzelevitch C. Sodium Channel blockade produces opposite electrophysiologic effects in canine ventricular epicardium and epicardium. Circ Res 1991; 69: 277–291.
[25] Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80: 805–811.
[26] Bennet P, Yazawa K, Makita N, et al. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995; 376: 683–685.
[27] Dumaine R, Wang Q, Keating M, et al. Multiple mechanisms of sodium channel-linked long QT syndrome. Circ Res 1996; 78: 916–924.
[28] Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 1998; 392: 293–296.
[29] Tohyou Y, Nakazawa K, Ozawa A, et al. A survey in the incidence of right bundle branch block with ST segment elevation among normal population. Jpn J Electrocardiol 1995; 15: 223–226.
[30] Namiki T, Ogura T, Kuwabara Y, et al. Five-year mortality and clinical characteristics of adult subjects with right bundle branch block and ST elevation. Circulation 1995; 93: 334.
[31] Hata Y, Chiba N, Hotta K, et al. Incidence and clinical significance of right bundle branch block and ST segment elevation in V1–V3in 6-to 18-year-old school children in Japan. Circulation 1997; 20: 2310.
[32] Kasanuki H, Ohnishi S, Ohtuka M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997; 95: 2277–2285.
[33] Proclemer A, Facchin D, Feruglio GA, Nucifora R. Fibrillazione ventricolare recidivante, blocco di branca destra, persistent sopraslivellamento del tratto ST in V1–V3: Una nuova syndroma aritmica? Descrizione di un caso clinico. G Ital Cardiol 1993; 23: 1211–1218.
[34] Brugada J, Brugada R, Brugada P. Right bundle branch block and ST segment elevation in leads V1–V3: A marker for sudden death in patients with no demonstrable structural heart disease. Circulation 1998; 97: 457–460.
[35] Corrado D, Nava A, Buja G. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996; 27: 443–448.
[36] Corrado D, Basso C, Nava A, Buja G, Thiene G. Pathologic substrates of right bundle branch block, persistent precordial ST segment elevation and sudden death in young people. Circulation 1996; 94: 626.
[37] Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061–1070.
[38] Brugada P. unpublished observations.
[39] Lukas A and Antzelevitch C. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. The antiarrhythmic effects of 4-aminopyridine. Cardiovasc Res 1996; 32: 593–603.
[40] Lukas A and Antzelevitch C. The contribution of K+ currents to electrical heterogeneity across the canine ventricular wall under normal and ischemic conditions. In Dhalla NS, Pierce GN, Panagia V (Eds.). Pathophysiology of Heart Failure 1996; Boston Academic Publishers pp. 440–456.
[41] Sun ZQ and Antzelevitch C. Ionic basis for the electrocardiographic J Wave (Abstr). Circulation 1996; 94: I–669.
[42] Yan GX and Antzelevitch C. Cellular basis for idiopathic VT/VF syndrome (Abstr). Circulation 1996; 94: I–625.
[43] Di Diego JM and Antzelevitch C. High [Ca2+]-induced electrical heterogeneity and extrasystolic activity in isolated canine ventricular epicardium: Phase 2 reentry. Circulation 1994; 89: 1839–1850.
[44] Di Diego JM and Antzelevitch C. Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues: Does activation of ATP-regulated potassium current promote phase 2 reentry. Circulation 1993; 88: 1177–1189.
[45] Langer GA, Brady AJ, Tan ST, Serena SD. Correlation of the glucoside response, the force staircase, and the action potential configuration in the neonatal rat heart. Circ Res 1975; 36: 744–752.
[46] Furukawa T, Myerburg RJ, Furukawa N, Bassett AL, Kimura S. Differences in transient outward currents of feline endocardial and epicardial myocytes. Circ Res 1990; 67: 1287–1291.
[47] Fedida D and Giles WR. Regional variations in action potentials and transient outward current in myocytes isolated from rabbit left ventricle. J Physiol (Lond.) 1991; 442: 191–209.
[48] Clark RB, Bouchard RA, Salinas-Stefanon E, Sanchez-Chapula J, Giles WR. Heterogeneity of action potential waveforms and potassium currents in rat ventricle. Cardiovasc Res 1993; 27: 1795–1799.
[49] Wettwer E, Amos GJ, Posival H, Ravens U. Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ Res 1994; 75: 473–482.
[50] Nabauer M, Beuckelmann DJ, Uberfuhr P, Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 1996; 93: 168–177.
[51] Antzelevitch C, Yan GX, Shimizu W, Burashnikov A. Electrical heterogeneity, the ECG, and cardiac arrhythmias. In Zipes DP and Jalife J (Eds.). Cardiac Electrophysiology: From Cell to Bedside 1998; Philadelphia W.B. Saunders Co. pp. 1–34.
[52] Antzelevitch C, Sicouri S, Lukas A, Nesterenko VV, Liu DW, Di Diego JM. Regional differences in the electrophysiology of ventricular cells: Physiological and clinical implications. In Zipes DP and Jalife J (Eds.). Cardiac electrophysiology: From cell to bedside 1995; Philadelphia W.B. Saunders Co. pp. 228–245.
[53] Antzelevitch C, Sicouri S, Litovsky SH, et al. Heterogeneity within the ventricular wall: Electrophysiology and pharmacology of epicardial, endocardial and M cells. Circ Res 1991; 69: 1427–49.
[54] Escande D, Loisance D, Planche C, Coraboeuf E. Age-related changes of action potential plateau shape in isolated human atrial fibers. Am J Physiol 1985; 249: H843–H850.
[55] Reder RF, Miura DS, Danilo P, Rosen MR. The electrophysiological properties of normal neonatal and adult canine cardiac Purkinje fibers. Circ Res 1981; 48: 658–668.
[56] Zygmunt AC. The calcium-activated conductance, Ito2, in canine ventricle is a chloride current (Abstr). Biophys J 1993; 64: A389.
[57] Di Diego JM, Sun ZQ, Antzelevitch C. Itoand action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol 1996; 271: H548–H561.
[58] Antzelevitch C. The Brugada syndrome. J Cardiovasc Electrophysiol 1998; 9: 513–516.
[59] Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR. The Brugada syndrome. Clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999; 33: 5–15.
[60] Chiale PA, Przybylski J, Laino RA, et al. Electrocardiographic changes evoked by ajmaline in chronic Chagas' disease without manifest myocarditis. Am J Cardiol 1982; 49: 14–20.
[61] Farre J. unpublished observation.
[62] Brugada P, Green M, Abdollah H, Wellens HJJ. Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: Importance of the type of ventricular arrhythmia induced and the number of premature stimuli required. Circulation 1984; 69: 87–92.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Z. Miloushev, J. A. Levine, M. A. Arbing, J. F. Hunt, G. S. Pitt, and A. G. Palmer III Solution Structure of the NaV1.2 C-terminal EF-hand Domain J. Biol. Chem., March 6, 2009; 284(10): 6446 - 6454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Noseworthy and C. Newton-Cheh Genetic Determinants of Sudden Cardiac Death Circulation, October 28, 2008; 118(18): 1854 - 1863. [Full Text] [PDF]
|
|
|
|
 |
|
 Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]
|
|
|
|
 |
|
 Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]
|
|
|
|
 |
|
 E Aksay, T Okan, and S Yanturali Brugada syndrome, manifested by propafenone induced ST segment elevation Emerg. Med. J., October 1, 2005; 22(10): 748 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Krittayaphong, G. Veerakul, K. Nademanee, and C. Kangkagate Heart rate variability in patients with Brugada syndrome in Thailand Eur. Heart J., October 1, 2003; 24(19): 1771 - 1778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priori, C. Napolitano, M. Gasparini, C. Pappone, P. D. Bella, U. Giordano, R. Bloise, C. Giustetto, R. De Nardis, M. Grillo, et al. Natural History of Brugada Syndrome: Insights for Risk Stratification and Management Circulation, March 19, 2002; 105(11): 1342 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Task Force on Syncope, European Society of Cardiol, M Brignole, P Alboni, D Benditt, L Bergfeldt, J.J Blanc, P.E Bloch Thomsen, J.G van Dijk, A Fitzpatrick, S Hohnloser, et al. Guidelines on management (diagnosis and treatment) of syncope Eur. Heart J., August 1, 2001; 22(15): 1256 - 1306. [Abstract] [PDF]
|
|
|
|
|
|
P. Brugada, J. Brugada, and R. Brugada The yet unresolved dilemma of syncope in Brugada syndrome Europace, January 1, 2001; 3(2): 157 - 158. [PDF]
|
|
|
|
|
|
N. Samniah, D. Iskos, S. Sakaguchi, K. G. Lurie, and D. G. Benditt Syncope in pharmacologically unmasked Brugada syndrome: indication for an implantable defibrillator or an unresolved dilemma? Europace, January 1, 2001; 3(2): 159 - 163. [Abstract] [PDF]
|
|
|
|
|
|
S. G. Priori, C. Napolitano, M. Gasparini, C. Pappone, P. Della Bella, M. Brignole, U. Giordano, T. Giovannini, C. Menozzi, R. Bloise, et al. Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome : A Prospective Evaluation of 52 Families Circulation, November 14, 2000; 102(20): 2509 - 2515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. JORDAENS Development of Europace Europace, January 1, 1999; 1(3): 149 - 150. [PDF]
|
|
|
|
|
|
P. Brugada Unravelling the mechanisms of symptoms in patients at risk of genetically determined cardiac arrhythmias Europace, January 1, 1999; 1(4): 218 - 219. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||